DNA Talks: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DNA Talks
Largest movements
- Receivables within one year -€1,799
down €1,799 (-1.5%), from €116,792 to €114,993
of which Other amounts receivable: -€1,799
- Trade debts +€9,013
up €9,013 (+13.6%), from €66,115 to €75,128
- Accrued charges and deferred income -€6,323
down €6,323 (-71.9%), from €8,800 to €2,477
- Profit (loss) carried forward -€5,127
down €5,127 (-2.8%), from -€183,561 to -€188,688
- Financial income -€3,015
no longer reported in 2025 (was €3,015)
- Gross operating margin -€1,997
down €1,997 (-105.7%), from -€1,889 to -€3,886
- Financial charges +€303
up €303 (+184.6%), from €164 to €467
- Depreciation +€212
up €212 (+50.7%), from €417 to €629
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €117,443 | €115,005 | -€2,437 | -2.1% |
| Formation expenses | 20 | €629 | - | -€629 | |
| Current assets | 29/58 | €116,814 | €115,005 | -€1,809 | -1.5% |
| Amounts receivable within one year | 40/41 | €116,792 | €114,993 | -€1,799 | -1.5% |
| Trade receivables | 40 | €114,928 | €114,928 | = | 0.0% |
| Other amounts receivable | 41 | €1,863 | €64 | -€1,799 | -96.5% |
| Cash at bank and in hand | 54/58 | €22 | €13 | -€10 | -42.9% |
| Total equity and liabilities | 10/49 | €117,443 | €115,005 | -€2,437 | -2.1% |
| Equity | 10/15 | -€165,011 | -€170,138 | -€5,127 | -3.1% |
| Contributions | 10/11 | €18,550 | €18,550 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€183,561 | -€188,688 | -€5,127 | -2.8% |
| Amounts payable | 17/49 | €282,454 | €285,143 | +€2,689 | +1.0% |
| Amounts payable within one year | 42/48 | €273,654 | €282,666 | +€9,013 | +3.3% |
| Trade debts | 44 | €66,115 | €75,128 | +€9,013 | +13.6% |
| Suppliers | 440/4 | €66,115 | €75,128 | +€9,013 | +13.6% |
| Other amounts payable | 47/48 | €207,539 | €207,539 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €8,800 | €2,477 | -€6,323 | -71.9% |
| Non-recurring operating income | 76A | €15,096 | - | -€15,096 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €417 | €629 | +€212 | +50.7% |
| Other operating charges | 640/8 | €141 | €144 | +€4 | +2.6% |
| Gross operating margin | 9900 | -€1,889 | -€3,886 | -€1,997 | -105.7% |
| Operating profit (loss) | 9901 | -€2,447 | -€4,659 | -€2,213 | -90.4% |
| Financial income | 75/76B | €3,015 | - | -€3,015 | |
| Recurring financial income | 75 | €3,015 | - | -€3,015 | |
| Financial charges | 65/66B | €164 | €467 | +€303 | +184.6% |
| Recurring financial charges | 65 | €164 | €467 | +€303 | +184.6% |
| Profit (loss) for the period before taxes | 9903 | €404 | -€5,127 | -€5,531 | |
| Profit (loss) for the period | 9904 | €404 | -€5,127 | -€5,531 | |
| Profit (loss) for the period to be appropriated | 9905 | €404 | -€5,127 | -€5,531 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.